Clearview Wealth Advisors’s bluebird bio BLUE Stock Holding History

Clearview Wealth Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8	Closed	-$3K	–	646
2021 Q1	$3K	Buy	+8	New	+$3.94K	﹤0.01%	519

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Clearview Wealth Advisors's BLUE Position: Q2 2021 in Review

Clearview Wealth Advisors sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 8 shares — an estimated $3K sold.

Clearview Wealth Advisors first reported a position in BLUE in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

Clearview Wealth Advisors reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
Clearview Wealth Advisors sold 8 bluebird bio shares in Q2 2021, an estimated $3K.
Clearview Wealth Advisors first reported a position in bluebird bio in Q1 2021 and held it in 1 quarter.
Clearview Wealth Advisors's bluebird bio position peaked at $3K in Q1 2021.
232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Clearview Wealth Advisors's 13F filing for Q2 2021, filed 30 Jul 2021.